A Pharmaceuticals (Generic formulation) entity from India is looking to raise strategic funding.

It is a generic formulation company involved in marketing and distributing generic branded products. It serves medicinal products in many different therapeutic segments including Diabetology, Endocrinology & other Metabolic Disorders to cover the majority of diseases. It is founded in 2011-2012.

Products under its portfolio:
210 – branded – (trademarks applied for all but 50% received so far).

Ask:
Looking to raise around 30 crores for expansion of company into newer geographic areas. By issuing fresh equity up to 10 %.

Promoters:
Four A grade promoters with 25 years’ of experience working with various multinational pharmaceutical companies.

Revenues:
2023(Expected) 85 Crores
Net profit -15 Crores

Future growth expectations: Expects to grow 20 -25% every year.

Business Divisions